Table 3.
Adjusted Prevalence Ratio of Low-dose Aspirin Use Among Adults Aged 40 and Over Eligible1 to Take Low-dose Aspirin for Secondary Prevention of Cardiovascular Disease, by Definition of Atherosclerotic Cardiovascular Disease and Demographic and Health Characteristics, United States, 20122
| Coronary Heart Disease and/or Stroke n=3,068 Adjusted prevalence ratio (95% CI) | Coronary Heart Disease Only n=2,007 Adjusted prevalence ratio (95% CI) | |
|---|---|---|
| Age (years) | ||
| 40–64 | 0.89 (0.82–0.96) | 0.87 (0.80–0.95) |
| ≥65 | Reference | Reference |
|
| ||
| Sex | ||
| Men | Reference | Reference |
| Women | 0.91 (0.85–0.97) | 0.90 (0.84–0.98) |
|
| ||
| Race | ||
| NH-White | Reference | Reference |
| NH-Black | 0.91 (0.83–0.99) | 0.88 (0.78–0.99) |
| Hispanics | 0.83 (0.72–0.95) | 0.84 (0.72–0.97) |
| Others | 0.90 (0.78–1.05) | 1.05 (0.94–1.18) |
|
| ||
| Education | ||
| <High school | Reference | Reference |
| High school | 0.96 (0.88–1.05) | 0.97 (0.88–1.07) |
| Some college | 0.97 (0.88–1.05) | 0.99 (0.90–1.09) |
| ≥College | 1.08 (0.99–1.18) | 1.07 (0.96–1.18) |
|
| ||
| BMI | ||
| Normal | Reference | Reference |
| Overweight | 1.07 (0.99–1.16) | 1.11 (1.00–1.23) |
| Obesity | 1.07 (0.99–1.15) | 1.12 (1.01–1.23) |
|
| ||
| Have Insurance | ||
| Yes | Reference | Reference |
| No | 0.92 (0.79–1.07) | 0.87 (0.74–1.03) |
|
| ||
| Ulcer | ||
| Yes | Reference | Reference |
| No | 0.97 (0.89–1.04) | 0.97 (0.88–1.06) |
|
| ||
| Arthitis3 | ||
| Yes | Reference | Reference |
| No | 0.99 (0.92–1.06) | 1.00 (0.93–1.08) |
|
| ||
| Number of risk factors4 | ||
| 0 | Reference | Reference |
| 1 | 1.13 (0.96–1.34) | 1.09 (0.91–1.31) |
| 2 | 1.23 (1.05–1.43) | 1.19 (1.00–1.41) |
| 3 | 1.36 (1.15–1.60) | 1.26 (1.05–1.53) |
| 4 | 1.50 (1.28–1.77) | 1.42 (1.18–1.71) |
|
| ||
| Number of risk factor5 odds ratio for linear trend | 1.39 (1.23–1.57) | 1.33 (1.16–1.54 |
An adult's eligibility to take low-dose aspirin is determined by either having been told by a health professional that s/he have coronary heart disease and/or stroke, or having been told by a health professional that s/he has coronary heart disease.
Data source: CDC/NCHS, National Health Interview Survey, 20121. All covariates were in the models simultaneously
Arthritis included arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia
Tested for a linear trend in the relationship between cardiovascular risk and aspirin use by substituting the number of risk factors as a continuous variable in the model
Tested for a linear trend in the relationship between cardiovascular risk and aspirin use by substituting the number of risk factors as a continuous variable in the model